{"id":52426,"date":"2022-12-29T17:02:20","date_gmt":"2022-12-29T16:02:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/u-s-diabetic-neuropathy-market-report-2022-adoption-of-inorganic-growth-strategies-fuels-sector-researchandmarkets-com\/"},"modified":"2022-12-29T17:02:20","modified_gmt":"2022-12-29T16:02:20","slug":"u-s-diabetic-neuropathy-market-report-2022-adoption-of-inorganic-growth-strategies-fuels-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/u-s-diabetic-neuropathy-market-report-2022-adoption-of-inorganic-growth-strategies-fuels-sector-researchandmarkets-com\/","title":{"rendered":"U.S. Diabetic Neuropathy Market Report 2022: Adoption of Inorganic Growth Strategies Fuels Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “U.S. Diabetic Neuropathy Market, by Drug by Type, by Route of Administration, by Distribution Channel – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nDiabetic neuropathy is a serious and common complication of type 1 and type 2 diabetes. Diabetic neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower leg, it develops slowly, sometimes over the course of decades. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy.\n<\/p>\n

\nThere are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. Peripheral neuropathy is the most common form of neuropathy.\n<\/p>\n

\nOver time, high blood glucose levels, also called blood sugar, and high levels of fats, such as triglycerides, in the blood from diabetes can damage your nerves. High blood glucose levels can also damage the small blood vessels that nourishes the nerves with oxygen and nutrients. There is no cure for diabetic neuropathy but the nerve pain can be managed with medication and exercise.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nIncreasing adoption of inorganic strategies such as collaborative agreement by key market players is expected to drive the U.S. diabetic neuropathy market over the forecast period.\n<\/p>\n

\nFor instance, in June 2020, NeuroMetrix, Inc., a medical device company, announced that they had signed a collaborative agreement with BioMedix, a manufacturer of diagnostic and surgical equipment, to comarket DPNCheck for peripheral neuropathy detection within medicare advantage. This agreement will provide complementary diagnostic tests to physicians and health plans by combining results from multiple diagnostic tests into one data exchange file for the electronic medical record system.\n<\/p>\n

\nKey features of the study:<\/strong>\n<\/p>\n